Physician profile
William A Frame
NPI 1326026709
$324.87
in general payments reported to CMS, 2019-2025
8 companies · $35.84 in 2025
The $35.84 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.72 · 2021: $16.28 · 2022: $50.58 · 2023: $62.81 · 2024: $144 · 2025: $35.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $98.32 | 2019-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $56.51 | 2024 | Exparel |
| Mindray Ds USA, INC. | $36.51 | 2024 | A7 Anesthesia System |
| Heron Therapeutics, INC. | $33.21 | 2024 | Aponvie |
| Chiesi USA, INC. | $31.21 | 2024-2025 | Cleviprex |
| Masimo Corporation | $26.50 | 2022 | |
| Edwards Lifesciences Corporation | $26.33 | 2023 | Hemosphere |
| Avanos Medical | $16.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Frame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.